DG McDevitt

718 total citations
9 papers, 122 citations indexed

About

DG McDevitt is a scholar working on Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, DG McDevitt has authored 9 papers receiving a total of 122 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in DG McDevitt's work include Atrial Fibrillation Management and Outcomes (2 papers), Receptor Mechanisms and Signaling (2 papers) and Cardiovascular Syncope and Autonomic Disorders (2 papers). DG McDevitt is often cited by papers focused on Atrial Fibrillation Management and Outcomes (2 papers), Receptor Mechanisms and Signaling (2 papers) and Cardiovascular Syncope and Autonomic Disorders (2 papers). DG McDevitt collaborates with scholars based in United Kingdom. DG McDevitt's co-authors include RG Shanks, J.G. Kelly, Derek Maclean, TJ Fitzsimons, JS McLay, John McEwen, AN Brown, D. B. Galloway, Ruth Lewis and S. Copeland and has published in prestigious journals such as British Journal of Clinical Pharmacology.

In The Last Decade

DG McDevitt

9 papers receiving 106 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DG McDevitt United Kingdom 6 40 29 23 19 17 9 122
J Bonelli Austria 8 75 1.9× 31 1.1× 21 0.9× 31 1.6× 16 0.9× 36 202
Joanne I. Moore United States 8 73 1.8× 53 1.8× 41 1.8× 21 1.1× 9 0.5× 15 232
W. P. Palmore United States 8 55 1.4× 100 3.4× 17 0.7× 22 1.2× 17 1.0× 14 325
J. Daniel United Kingdom 4 46 1.1× 21 0.7× 16 0.7× 18 0.9× 5 0.3× 6 152
J. P. Currie United Kingdom 7 24 0.6× 33 1.1× 14 0.6× 32 1.7× 9 0.5× 12 278
R M Beer Israel 12 26 0.7× 63 2.2× 57 2.5× 68 3.6× 32 1.9× 14 450
Luciana Bortoluzzi Italy 4 39 1.0× 26 0.9× 150 6.5× 20 1.1× 3 0.2× 5 377
Carla Sala Italy 7 173 4.3× 31 1.1× 26 1.1× 9 0.5× 4 0.2× 15 234
E. K. Marshall United States 7 9 0.2× 24 0.8× 29 1.3× 9 0.5× 9 0.5× 13 134
Jiří Jelínek Czechia 10 95 2.4× 79 2.7× 82 3.6× 10 0.5× 11 0.6× 39 333

Countries citing papers authored by DG McDevitt

Since Specialization
Citations

This map shows the geographic impact of DG McDevitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DG McDevitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DG McDevitt more than expected).

Fields of papers citing papers by DG McDevitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DG McDevitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DG McDevitt. The network helps show where DG McDevitt may publish in the future.

Co-authorship network of co-authors of DG McDevitt

This figure shows the co-authorship network connecting the top 25 collaborators of DG McDevitt. A scholar is included among the top collaborators of DG McDevitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DG McDevitt. DG McDevitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
McDevitt, DG, et al.. (1994). Cardiac effects of the beta 3‐adrenoceptor agonist BRL35135 in man.. British Journal of Clinical Pharmacology. 37(4). 363–369. 36 indexed citations
2.
Lewis, Ruth, et al.. (1991). Magnesium deficiency may be an important determinant of ventricular ectopy in digitalised patients with chronic atrial fibrillation.. British Journal of Clinical Pharmacology. 31(2). 200–203. 6 indexed citations
3.
Maclean, Derek, et al.. (1988). Atenolol‐nifedipine combinations compared to atenolol alone in hypertension: efficacy and tolerability.. British Journal of Clinical Pharmacology. 25(4). 425–431. 12 indexed citations
4.
McDevitt, DG, et al.. (1988). Factors affecting the clinical response to treatment with digoxin and two calcium antagonists in patients with atrial fibrillation.. British Journal of Clinical Pharmacology. 25(5). 603–606. 5 indexed citations
5.
Kelly, J.G., et al.. (1985). Effects of ranitidine on the disposition of metoprolol.. British Journal of Clinical Pharmacology. 19(2). 219–224. 21 indexed citations
6.
Brown, AN, et al.. (1985). Human pharmacokinetic and pharmacodynamic studies on Ro31‐1118, a new beta‐adrenoceptor antagonist.. British Journal of Clinical Pharmacology. 19(3). 319–327. 7 indexed citations
7.
McDevitt, DG, et al.. (1984). Central effects of single oral doses of propranolol in man.. British Journal of Clinical Pharmacology. 17(1). 31–36. 28 indexed citations
8.
Cooper, S.J., et al.. (1984). Pharmacodynamics and pharmacokinetics of digoxin in the presence of lithium.. British Journal of Clinical Pharmacology. 18(1). 21–25. 2 indexed citations
9.
McDevitt, DG, et al.. (1983). Standardised isoprenaline sensitivity tests‐a comparison of existent methods.. British Journal of Clinical Pharmacology. 15(2). 167–172. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026